"We cannot recommend peptide therapies that lack regulatory approval and adequate clinical trial evidence," stated the AACE 2023 obesity guideline update, which specifically addressed the proliferation of unapproved compounded peptides for weight management [9]
In September 2023 the FDA placed BPC-157 in Category 2 of its 503A interim bulk-substances policy, citing immunogenicity and peptide-characterization concerns, effectively excluding it from the 503A compounding bulk-substances list
Wipe the stopper with a fresh alcohol pad
It's all part of "the circus of unproven, expensive and possibly dangerous" offerings promoted by wellness and longevity clinics, said Topol, who has written about the industry
We believe professionals and their organizations deserve trusted, well-sourced peptides-made with care and integrity. We understand how difficult it can be to find a consistent and affordable source for peptide-based materials
Did you know most health insurance plans cover mental health treatment